Cognitive Diagnostics Market Report 2026

Cognitive Diagnostics Market Overview

• Cognitive Diagnostics market size has reached to $6.25 billion in 2025 • Expected to grow to $17.46 billion in 2030 at a compound annual growth rate (CAGR) of 22.7% • Growth Driver: Rising Neurological Disorders To Accelerate Growth In The Cognitive Diagnostics Market • Market Trend: Enhancing Cognitive Health Management With Advanced Neuropsychological Testing Tools • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cognitive Diagnostics Market?

Cognitive diagnostics refers to the process of assessing and evaluating an individual's cognitive functions to diagnose and understand cognitive disorders or impairments. This field focuses on identifying issues related to memory, attention, language, problem-solving, and other cognitive abilities. It involves a variety of methods and tools to analyze cognitive performance and determine the presence of conditions such as dementia, Alzheimer’s disease, traumatic brain injury, or other cognitive impairments. The main types of cognitive diagnostics include brain imaging tests, laboratory testing, mental status testing, rapid home screening tests, neuropsychological testing, electroencephalograms (EEG), cognitive function and behavioral tests, and the behavioral tests, and the neuropsychiatric inventory questionnaire (NPI-Q). Brain imaging tests are techniques used to visualize the structure and function of the brain, such as MRI and CT scans, to identify abnormalities or changes that may indicate cognitive disorders. The indication types include Alzheimer’s disease, attention deficit or hyperactivity disorder, dementia, epilepsy-related cognitive dysfunction, mild cognitive impairment, Parkinson’s disease-related cognitive dysfunction, stroke-related cognitive dysfunction, traumatic brain injury, and others. End users are categorized into hospitals, neurology clinics, cognitive behavioral therapy centers, rehabilitation centers, academic and research institutes, diagnostic imaging centers, and home care settings.

What Is The Cognitive Diagnostics Market Growth Forecast?

The cognitive diagnostics market size is expected to see exponential growth in the next few years. It will grow to $17.46 billion in 2030 at a compound annual growth rate (CAGR) of 22.7%. The growth in the forecast period can be attributed to increasing investments in digital diagnostics, rising demand for early-stage cognitive disorder detection, expansion of home-based cognitive assessment tools, growing integration of ai in clinical decision support, increasing focus on personalized cognitive care. Major trends in the forecast period include increasing use of AI-based cognitive assessment tools, rising adoption of digital cognitive screening platforms, growing deployment of neuroimaging analytics, expansion of remote cognitive testing solutions, enhanced focus on early disease detection.

Global Cognitive Diagnostics Market Segmentation

1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q) 2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications 3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings Subsegments: 1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG) 2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease 3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools 4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests 5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests 6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders 7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments 8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.

What Is The Driver Of The Cognitive Diagnostics Market?

The escalating incidence of neurological disorders is expected to propel the growth of the cognitive diagnostics market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord, and nervous system, impairing their function and leading to symptoms such as cognitive decline, motor dysfunction, and sensory abnormalities. The rise in neurological disorders is driven by an increased prevalence of age-related conditions such as Alzheimer's and Parkinson's disease. Moreover, hereditary factors, along with environmental toxins, stress, unhealthy diets, and sedentary lifestyles, contribute to the increasing prevalence of neurological disorders. Cognitive diagnostics are used in neurological diseases to assess, detect, and monitor cognitive impairments, aiding in the early diagnosis and management of conditions like Alzheimer's and Parkinson's disease. For instance, in May 2024, according to a report by the Alzheimer's Association, a U.S.-based nonprofit organization dedicated to Alzheimer's care, support, and research, the number of Americans aged 65 and older diagnosed with Alzheimer's dementia rose from 6.5 million in 2022 to an estimated 6.9 million in 2024. Therefore, the escalating incidence of neurological disorders is driving the growth of the cognitive diagnostics industry.

Key Players In The Global Cognitive Diagnostics Market

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants

Global Cognitive Diagnostics Market Trends and Insights

Major companies operating in the cognitive diagnostics market focus on real-time insights into cognitive health with technological advancements in diagnostic tools such as neuropsychological testing platforms, to enhance accuracy, efficiency, and comprehensiveness in cognitive assessments. Neuropsychological testing platforms are specialized digital tools designed to assess cognitive functions through standardized tests, including memory, attention, and problem-solving skills. For instance, in April 2024, BrainCheck Inc., a US-based digital health company powering positive progress in cognitive health, unveiled its comprehensive digital cognitive assessment platform at the American Academy of Neurology (AAN) Annual Meeting, showcasing its advanced tools for cognitive screening, assessment, and care planning. The platform, including Assess, Screen, and Plan, offers clinicians a modern solution to streamline cognitive health management with mobile, digital technology that ensures accuracy and ease of use. This innovation aims to enhance the efficiency and quality of care for patients and providers by offering nuanced, evidence-based recommendations and comprehensive care planning.

What Are Latest Mergers And Acquisitions In The Cognitive Diagnostics Market?

In July 2024, Lantheus Holdings, Inc., a US-based radiopharmaceutical company, acquired Meilleur Technologies Inc for an undisclosed amount. This acquisition aims to enhance Lantheus's portfolio in Alzheimer's disease diagnostics by combining Meilleur's NAV-4694, which detects beta-amyloid plaques, with Lantheus' existing PET agent MK-6240 for tau tangles. This synergy allows Lantheus to offer a comprehensive diagnostic solution for Alzheimer's, supporting both early detection and the assessment of disease-modifying treatments. Meilleur Technologies Inc. is a US-based company specializing in developing radiopharmaceutical diagnostics for cognitive conditions.

Regional Outlook

North America was the largest region in the cognitive diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cognitive Diagnostics Market?

The cognitive diagnostics market consists of revenues earned by entities by providing services such as consultation services, rehabilitation services, and therapy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cognitive diagnostics market also includes sales of cognitive assessment software, neuropsychological testing kits, smartwatches and wearables with cognitive monitoring capabilities, and brain training software and apps. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cognitive Diagnostics Market Report 2026?

The cognitive diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cognitive diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.